Operating Margin in % of AbbVie Inc. from 2016 to Q3 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
AbbVie Inc. quarterly/annual Operating Margin history and growth rate from 2016 to Q3 2025.
  • AbbVie Inc. Operating Margin for the quarter ending September 30, 2025 was 15.2 %, a 39.1% decline year-over-year.
  • AbbVie Inc. annual Operating Margin for 2024 was 16.2 %, a 31% decline from 2023.
  • AbbVie Inc. annual Operating Margin for 2023 was 23.5 %, a 24.7% decline from 2022.
  • AbbVie Inc. annual Operating Margin for 2022 was 31.2 %, a 2.16% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)

AbbVie Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 15.2 -9.73 -39.1% Jul 1, 2025 Sep 30, 2025
Q2 2025 18.8 -3.51 -15.7% Apr 1, 2025 Jun 30, 2025
Q1 2025 17.6 -5.95 -25.3% Jan 1, 2025 Mar 31, 2025
Q4 2024 16.2 -7.27 -31% Oct 1, 2024 Dec 31, 2024
Q3 2024 24.9 -2.43 -8.89% Jul 1, 2024 Sep 30, 2024
Q2 2024 22.3 -8.72 -28.1% Apr 1, 2024 Jun 30, 2024
Q1 2024 23.5 -4.99 -17.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 23.5 -7.72 -24.7% Oct 1, 2023 Dec 31, 2023
Q3 2023 27.3 -3.27 -10.7% Jul 1, 2023 Sep 30, 2023
Q2 2023 31 +0.71 +2.34% Apr 1, 2023 Jun 30, 2023
Q1 2023 28.5 -4.19 -12.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 31.2 -0.69 -2.16% Oct 1, 2022 Dec 31, 2022
Q3 2022 30.6 +0.5 +1.66% Jul 1, 2022 Sep 30, 2022
Q2 2022 30.3 +1.38 +4.77% Apr 1, 2022 Jun 30, 2022
Q1 2022 32.7 +9.05 +38.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 31.9 +7.09 +28.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 30.1 +1.64 +5.76% Jul 1, 2021 Sep 30, 2021
Q2 2021 29 -1.22 -4.04% Apr 1, 2021 Jun 30, 2021
Q1 2021 23.6 -16.2 -40.7% Jan 1, 2021 Mar 31, 2021
Q4 2020 24.8 -14.2 -36.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 28.5 +8.41 +42% Jul 1, 2020 Sep 30, 2020
Q2 2020 30.2 +8.32 +38.1% Apr 1, 2020 Jun 30, 2020
Q1 2020 39.9 +20 +101% Jan 1, 2020 Mar 31, 2020
Q4 2019 39 +19.5 +100% Oct 1, 2019 Dec 31, 2019
Q3 2019 20 -12.9 -39.2% Jul 1, 2019 Sep 30, 2019
Q2 2019 21.9 -10.9 -33.3% Apr 1, 2019 Jun 30, 2019
Q1 2019 19.9 -14 -41.4% Jan 1, 2019 Mar 31, 2019
Q4 2018 19.5 -14.3 -42.4% Oct 1, 2018 Dec 31, 2018
Q3 2018 33 -4 -10.8% Jul 1, 2018 Sep 30, 2018
Q2 2018 32.8 -3.71 -10.2% Apr 1, 2018 Jun 30, 2018
Q1 2018 33.9 -2.21 -6.12% Jan 1, 2018 Mar 31, 2018
Q4 2017 33.8 -2.6 -7.14% Oct 1, 2017 Dec 31, 2017
Q3 2017 37 Jul 1, 2017 Sep 30, 2017
Q2 2017 36.5 Apr 1, 2017 Jun 30, 2017
Q1 2017 36.1 Jan 1, 2017 Mar 31, 2017
Q4 2016 36.4 Oct 1, 2016 Dec 31, 2016

AbbVie Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 16.2 -7.27 -31% Jan 1, 2024 Dec 31, 2024
2023 23.5 -7.72 -24.7% Jan 1, 2023 Dec 31, 2023
2022 31.2 -0.69 -2.16% Jan 1, 2022 Dec 31, 2022
2021 31.9 +7.09 +28.6% Jan 1, 2021 Dec 31, 2021
2020 24.8 -14.2 -36.4% Jan 1, 2020 Dec 31, 2020
2019 39 +19.5 +100% Jan 1, 2019 Dec 31, 2019
2018 19.5 -14.3 -42.4% Jan 1, 2018 Dec 31, 2018
2017 33.8 -2.6 -7.14% Jan 1, 2017 Dec 31, 2017
2016 36.4 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.